Ad
Sunday, 11 September 2016
U.S. Justice Department subpoenas Taro over generic drug pricing
WASHINGTON (Reuters) - Taro Pharmaceutical Industries Ltd. and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed late on Friday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment